Tipsheet
What matters at India’s listed companies
The Close / 1 Jun 2026 · 4:00 PM IST

Wockhardt cracks the FDA with India's first novel molecule

The pharma milestone overshadows a day heavy on micro-cap raises, order wins, and governance red flags across the breadth of India's listed space.

Nifty 500 11,147.55 +0.70%
Nifty Midcap 150 7,757.15 +0.66%
Nifty Smallcap 250 5,861.60 +0.30%
Nifty Microcap 250 25,369.85 0.00%
Major NSE sectoral indices latest
IndexLevelMove
Bank Nifty 58,291.50 +0.61%
Nifty Auto 27,353.95 +1.36%
Nifty Energy 39,481.45 +0.77%
Nifty Financial Services 29,422.60 0.00%
Nifty FMCG 50,196.35 +0.20%
Nifty Healthcare 16,481.35 0.00%
Nifty IT 27,276.45 -0.59%
Nifty Media 1,497.95 -0.95%
Nifty Metal 12,722.45 +0.98%
Nifty Pharma 25,866.25 +0.47%
Nifty Private Bank 16,648.10 +2.00%
Nifty PSU Bank 8,333.95 -0.88%
Nifty Realty 906.95 +1.81%
Nifty Cement 15,338.90 0.00%
Nifty Chemicals 30,222.70 0.00%
Nifty Consumer Durables 37,376.45 0.00%
Nifty Oil & Gas 11,261.10 0.00%
Market map
  • Large-cap pharma delivered the cycle's most significant regulatory win; large-cap realty added pipeline scale with a Greater Noida land deal.
  • Mid-cap construction and IT signals were constructive, with NCC's order book thickening and Cyient making an AI acquisition, while Fiem pointed to a four-wheeler pivot.
  • Micro-cap governance was the day's risk cluster: auditors quitting mid-fraud probe, unverified assets, and a CFO departure with no successor.
  • Micro-cap capital raises were extreme in scale, with three issuances each exceeding the company's own listed value, testing the limits of shareholder patience.
By size
Mega cap 2 Earnings / Other ₹3.33 L cr Large cap 2 M&A / Other ₹87,678 cr Mid cap 3 M&A / Order Wins ₹25,360 cr Small cap 1 Other ₹1,883 cr Micro cap 6 Credit / Earnings ₹833 cr
By sector
Pharmaceuticals 1 Large cap Real Estate 1 Large cap Engineering - Construction 1 Mid cap IT - Software 1 Mid cap Transformers 1 Micro cap Trading 1 Micro cap Pesticides 1 Micro cap Diversified 1 Micro cap
What moved today14
WOCKPHARMA Other Large cap Pharmaceuticals

Wockhardt Ltd.

Wockhardt's ZAYNICH became the first novel molecule from an Indian pharma company to win US FDA approval, posting an 89% composite cure rate against meropenem's 68.4% in Phase 3. For a company with a ₹34,983 crore market cap that has lived on R&D promise for decades, this converts a long-running binary bet into a commercial asset targeting over 600,000 annual US hospitalisations. The question now is not science but execution: how fast Wockhardt can manufacture and launch in a market that rewards speed.

89.0% vs 68.4%
ZAYNICH composite cure rate vs
₹31,933 cr
Large cap mcap
149.92x
P/E
+464.44%
PAT
+29.88%
Rev
0.43x
D/E
1-week price +39.58% · 1wk
Read the note
GODREJPROP M&A Large cap Real Estate

Godrej Properties Ltd.

Godrej Properties secured a 23.2-acre plot in Greater Noida with an estimated revenue potential of ₹7,000 crore, exceeding its entire FY26 consolidated revenue of ₹5,131 crore and representing 13% of its market cap. This is not a land bank footnote; it is a statement about the scale at which Godrej is willing to commit capital in a single geography. The open question is pace of absorption in Greater Noida, where launches have multiplied and price discovery remains contested.

₹7,000 cr
Estimated revenue potential for
₹55,745 cr
Large cap mcap
30.13x
P/E
+34.73%
PAT
+62.99%
Rev
0.71x
D/E
1-week price -0.72% · 1wk
Read the note
NCC Order Wins Mid cap Engineering - Construction

NCC Ltd.

NCC booked ₹1,837 crore in new orders during May alone, adding 10% to its annual standalone revenue in a single month on top of an already-heavy ₹83,004 crore order book. The wins span diversified segments, which matters for a mid-cap builder that needs margin stability more than headline growth. With FY26 PAT down nearly 20%, the backlog is the promise; delivery is the test.

₹1,837.01 cr
Total new orders secured by NCC
₹9,643 cr
Mid cap mcap
14.28x
P/E
-19.67%
PAT
+1.66%
Rev
0.22x
D/E
1-week price -2.23% · 1wk
Read the note
CYIENT M&A Mid cap IT - Software

Cyient Ltd.

Cyient acquired TAO Digital, a Santa Clara-based AI-native data and product engineering firm, for undisclosed terms, hosting a dedicated investor call that signals management treats the deal as a core strategic pillar. For a mid-cap IT services company where revenue barely grew in FY26 and PAT fell 65%, buying AI capability is a necessary move. The read-through for the broader engineering services sector is that organic build is no longer fast enough.

Undisclosed
Financial terms of the TAO
₹9,850 cr
Mid cap mcap
23.02x
P/E
-64.74%
PAT
+0.93%
Rev
0.03x
D/E
1-week price -0.01% · 1wk
Read the note
ALFATRAN Order Wins Micro cap Transformers

Alfa Transformers Ltd.

Alfa Transformers, a micro-cap with a ₹39 crore market cap, won a ₹63 crore order, representing 157% of its entire listed value, to supply 12,000 transformers to a state-owned utility. The contract provides a defined timeline and a credible counterparty, which is rare for a company this small. The real test is whether a nano-cap can scale manufacturing to deliver a single order that dwarfs its annual revenue.

₹63 cr
Order, or ~157% of Alfa's ₹40 cr
₹40.99 cr
Micro cap mcap
-813.04%
PAT
-23.37%
Rev
0.41x
D/E
1-week price -3.99% · 1wk
Read the note
ALKAINDIA Credit Micro cap Trading

Audroc Ltd.

Audroc Ltd. proposes to raise ₹80 crore through convertible warrants, 27 times its ₹3 crore market cap, which would leave existing shareholders owning just 3% of the expanded equity if fully converted. This is not a capital raise; it is a wholesale replacement of the company's ownership structure. The board has approved it, but the scale relative to the business demands clarity on where the money is going and who the eventual owners will be.

27x
Proposed ₹80 crore raise relative
₹3.28 cr
Micro cap mcap
17.94x
P/E
+315.97%
PAT
2.74x
D/E
Read the note
SKM Credit Micro cap Pesticides

SK Minerals & Additives Ltd.

SK Minerals plans to raise ₹222 crore from convertible warrants, equal to 45% of its market cap, with potential dilution of up to 49% on full conversion. Promoters are committing to over half the issue, which reads as confidence in a pesticides micro-cap that just posted 66% profit growth. The money needs to fund real capacity, not just shore up a balance sheet carrying a 1.89x debt-equity ratio.

₹222 cr
Capital to be raised from 60 lakh
₹461 cr
Micro cap mcap
25.46x
P/E
46.23%
ROE
1.89x
D/E
1-week price -0.42% · 1wk
Read the note
SKILVEN Regulatory Micro cap Diversified

Skyline Ventures India Ltd.

Skyline Ventures' auditor quit mid-fraud investigation, a new forensic report has landed, and the alleged fraud of ₹10.45 crore exceeds the company's entire ₹9.12 crore market cap. For a firm already in NCLT insolvency, the auditor walking away is not a procedural event; it signals the books may not be salvageable under the current structure. The strategic acquisition filed alongside these disclosures reads like a workaround for frozen data, not a growth plan.

₹10.45 cr
Alleged fraud under
₹8.73 cr
Micro cap mcap
-371.43%
PAT
0.32x
D/E
1-week price 0.00% · 1wk
Read the note
WARDWIZFBL Earnings Micro cap Solvent Extraction

Wardwizard Foods and Beverages Ltd.

Wardwizard Foods swung to profit on ₹237.73 crore in FY26 revenue, up 156% year-on-year, but its auditors could not verify nearly ₹37 crore in assets and liabilities. For a ₹303 crore market-cap company, unverified assets that amount to over 10% of the balance sheet are a material transparency gap. The profit headline is real, but the audit qualification makes the earnings quality uninvestable until resolved.

₹237.73 cr
FY26 revenue, up 156% from the
₹246 cr
Micro cap mcap
187.62x
P/E
+342.01%
PAT
+3.35%
Rev
0.39x
D/E
1-week price -1.92% · 1wk
Read the note
NHCFOODS Other Micro cap Consumer Food

NHC Foods Ltd.

NHC Foods is investing ₹202 crore into a newly formed UK subsidiary, more than 2.5 times its own ₹77 crore market cap, into a shell with no operating history. Prior context showed consolidated PAT growth of 74% on the back of the Conquer Enterprises acquisition, but standalone profitability was already slipping. The scale of the overseas bet against a company this size raises the question of whether this is expansion or capital flight.

₹202 cr
Investment into new UK
₹73.01 cr
Micro cap mcap
6.16x
P/E
+641.81%
PAT
+92.07%
Rev
0.38x
D/E
1-week price -6.03% · 1wk
Read the note
ADANIENSOL Other Mega cap Power Generation

Adani Energy Solutions Ltd.

Adani Energy Solutions' CFO resigned and was replaced within one day by an internal successor, signaling a planned transition rather than a surprise exit. For a mega-cap utility in a heavy capex phase with a 1.82x debt-equity ratio, continuity in the finance seat is the only thing that matters. The speed of the handover confirms this was choreographed, but the market should watch the new CFO's first capital-allocation calls closely.

1 day
Time between CFO resignation and
₹1.81 L cr
Mega cap mcap
79.35x
P/E
+1.26%
PAT
+16.76%
Rev
2.02x
D/E
1-week price +0.33% · 1wk
Read the note
POWERINDIA Earnings Mega cap Electric Equipment

Hitachi Energy India Ltd.

Hitachi Energy announced a ₹2,000 crore Vadodara investment, betting on India's transformer supply gap amid a data-center-driven grid buildout, while closing FY26 with a record ₹29,555 crore order backlog. EBITDA margins expanded from 9.3% to 15.4%, showing the backlog is converting into real profitability. For a mega-cap at ₹1.62 lakh crore, the message is that the binding constraint on India's energy transition is now manufacturing capacity, not demand.

₹29,555 cr
Record order backlog at the end
₹1.51 L cr
Mega cap mcap
153.25x
P/E
+79.71%
PAT
+46.21%
Rev
0x
D/E
1-week price -1.18% · 1wk
Read the note
FIEMIND Other Mid cap Auto Ancillary

Fiem Industries Ltd.

Fiem Industries guided ₹100-150 crore from its new four-wheeler vertical in FY27, backed by orders from Mahindra and validation work with Mercedes-Benz, after posting ₹253.87 crore in FY26 net profit. The ₹200 crore two-year capex commitment shows the company is serious about funding the ramp into a segment that moves it beyond two-wheeler cyclicality. This is the first concrete growth vector outside its legacy business.

₹253.87 cr
FY26 net profit, up 24.4% on the
₹5,867 cr
Mid cap mcap
22.95x
P/E
+20.59%
PAT
+17.49%
Rev
0x
D/E
1-week price +0.59% · 1wk
Read the note
IPL Other Small cap Agrochemicals

India Pesticides Ltd.

India Pesticides secured EU fungicide approval, opening access to 27 developed-market economies for a small-cap agrochemicals company with ₹1,832 crore in market cap. The regulatory clearance removes the biggest non-tariff barrier, but the commercial payoff remains unquantified. The test is whether the company can convert regulatory access into actual distribution in a market where EU buyers demand consistency Indian producers have not always delivered.

₹1,893 cr
Mkt cap of the micro-cap now
₹1,883 cr
Small cap mcap
15.72x
P/E
+40.61%
PAT
+28.59%
Rev
0.06x
D/E
Read the note
Management changed its story
  • CEO Nimesh Desai initially attributed ₹14 crore of inventory to the canceled Turkish Aerospace order, then minutes later claimed none of the inventory was related to that order. For a micro-cap pivoting to domestic defense after losing a ₹110 crore export contract, contradictory accounting of stranded inventory is a credibility problem the company cannot afford.

    TECHERA concall note
  • Management pushed the CCS facility commissioning from Q3 FY27 to Q1 FY28 without citing a specific reason, contradicting its own February 2026 timeline. For a company promising ₹650-675 crore in FY27 revenue, a key capex date slipping by a quarter without explanation makes the margin recovery story harder to trust.

    SIGACHI concall note
  • Management projected 45% EBITDA growth in November 2025 and February 2026, then delivered 24.6% for FY26, while the promised divestment of non-core services slipped from March 2026 to H1 FY27. The company is now asking investors to trust a ₹9,000 crore revenue target by FY30, but it has missed its own numbers two years running.

    AXISCADES concall note
From the calls
  • Patanjali Foods extended ₹700-800 crore in customer credit to protect edible oil market share during a 294 bps commodity cost spike, with CEO Sanjeev Asthana calling the volatility 'helpful' for large players. Edible oil EBITDA margins held at 2.58%, and management is guiding for 4% margins in FY27. The read-through is that scale players are trading cash for share, leaving smaller competitors exposed if input costs stay elevated.

    PATANJALI concall note
  • Axiscades' FY26 revenue of ₹1,159 crore missed internal targets as ₹142 crore in revenue recognition slipped to FY27 due to suppliers redirecting materials to war-related programs. EBITDA margins expanded 150 bps to 15.3%, but the repeated miss on self-set targets erodes the credibility of the FY30 ₹9,000 crore ambition. The defense pivot is logical, but management needs to stop overpromising and underdelivering.

    AXISCADES concall note
  • EMS management abandoned its 20% revenue growth and 15-18% margin guidance after reporting a 36% revenue decline in FY26, while 100 crore in unbilled inventory accumulated on the balance sheet. The company is now targeting ₹1,000 crore revenue for FY27, but the shift from confident quantified targets to inventory-dependent hopes is a governance credibility issue, not just an operational one.

    EMSLIMITED concall note
Tomorrow
  • India Railway Freight (YoY): prior 3.21%, tracks goods movement momentum.
  • India Non-Food Credit: watch for the weekly banking liquidity pulse.
  • India Portfolio Net Equity Flows: prior -$6.47 bn, foreign outflows remain the macro overhang.
  • India Corporate Bond Issuance (YoY): prior -15.68%, credit demand signal for rate-sensitive sectors.